Based in the Washington D.C. Metro area, BioFortis is a leading provider of precision medicine technology solutions. Its flagship product, Labmatrix®, is a web-based database application that addresses the needs in clinical trial sample & consent tracking, study subject & biospecimen management, and collaborative clinical & translational research programs. In May 2018, BioFortis was acquired by Q2 Solutions. With enterprise-grade capabilities for importing, integrating, and access controlling multiple eClinical and bioresearch data collections in a tightly-linked and regulatory-compliant manner, Labmatrix further empowers its users to easily ask sophisticated questions and generate scientific insights/reports, thus breaking down the technical barriers to big & complex data access and exploration.